Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFCAP.L Regulatory News (FCAP)

  • There is currently no data for FCAP

Trading Update

1 Apr 2020 07:00

RNS Number : 3210I
finnCap Group PLC
01 April 2020
Β 

1 April 2020

Β 

finnCap Group plc

("finnCap" or the "Group")

Β 

Trading Update

Β 

The Board is pleased to announce that the Group's trading performance since the announcement of 27 February has been in line with the Board's cautious expectations set out at that date. The second half trading performance is expected to be broadly breakeven with the equity capital markets division performing in line with the first half and the M&A division behind, as was previously stated. Turnover for the year is expected to be approximately Β£25.8m (11 months ended 31 March 2019: Β£24.5m).

Β 

An indication of how rapidly the world has changed is that on 27 February we only notedΒ the spread of Covid19 and yet five weeks later the government has implemented extreme social and economic measures in response to Covid19 and the United Kingdom is now in a "lockdown". Clearly these factors are expected to have a material negative impact on the Group's performance in the financial year to 31 March 2021 ("FY 2021"). However, the nature and the timescale of such impact is currently very uncertain. For the time being we still have a strong pipeline of M&A deals for Q1 FY 2021, albeit we expect to see a number of deals pulled or delayed, and the equity capital markets division continues to complete transactions.

Β 

In response to recent events the Group has moved all of its employees to remote working and is pleased to note this has had no material impact on our ability to operate to date. The Board has also reviewed the Group's operating expenses and taken swift action to minimise the financial impact of the uncertainty caused by Covid19. The measures taken include salary and fee sacrifices for all Board members for a period of three months (being 100 per cent of fees for non executive directors and between 92.5 per cent. and 44.0 per cent. of salary for executive directors), salary sacrifices by Group employees for three months, the furloughing of a number of staff and the cancellation or deferral of all discretionary expenditure. Together with the cost reductions referred to in the announcement of 27 February (which included the closure of the Slide Rule Fund), these actions -will reduce the cash monthly operating expenses of the Group to be 31% lower than those incurred in February 2020.

Β 

The Board intends to maintain a strong balance sheet and currently has financial resources well in excess of its regulatory requirements. The Group will take advantage of its ability to defer payment of VAT in line with the government's proposals. The Board has also taken the difficult decision that it will not pay the second dividend for the year ended 31 March 2020 in light of the current crisis and the cash conservation measures outlined above.

Β 

The Board is planning for a very difficult trading period ahead, particularly in the Group's M&A division. In light of this it is pleasing that the Group's equity capital markets division has continued to advice on deals throughout the last few weeks including equity fundraises for Synairgen plc, PCI-Pal PLC and Trackwise Designs PLC, and some of the fees associated with these will be recognised in FY 2021. The Group has also continued to generate secondary trading commission, make markets profitably, sign up retained clients in the equity capital markets division and secure mandates in the M&A division since the beginning of March.

Β 

Our ability to do this and move to operating remotely is testament to the dedication and quality of our employees who have quickly adjusted to the current environment. In order to recompense staff for sacrificing salary for the next three months, the Board today intends to grant options over approximately 5.3m ordinary shares exercisable at a price of 1p each (representing 3.0% of the existing issued share capital and granted on the basis of 10 options for every pound of salary forgone) which will be exercisable from 1 October 2021. No directors are receiving options.

Β 

The trading environment has never been more uncertain. However, with a strong balance sheet strengthened by the actions that we have taken, we believe that we are well placed to weather the storm and to continue to service our clients to the highest standard.

Β 

Β 

Β 

Β 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Β 

Β 

Contacts

finnCap Group plc Tel: +44 (0) 20 7220 0500

Sam Smith, Chief Executive Officer investor.relations@finncap.com

Tom Hayward, Chief Financial Officer

Β 

Grant Thornton (Nominated Adviser) Β Tel: +44 (0) 20 7383 5100

Philip Secrett/Samantha Harrison/Seamus Fricker

Β 

finnCap Ltd (Broker) Tel: +44 (0) 20 7220 0500

Rhys Williams

Tim Redfern

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
TSTUASRRROUOOUR
Date   Source Headline
3rd Jan 20207:00 amRNSTotal Voting Rights
29th Nov 20197:00 amRNSBlock Admission of Shares
25th Nov 20197:00 amRNSInterim results and interim dividend
8th Oct 20197:00 amRNSTrading Update
26th Sep 20191:40 pmRNSResult of AGM
3rd Sep 20193:44 pmRNSExercise of Options and Total Voting Rights
29th Aug 201911:51 amRNSDirector/PDMR Shareholding
30th Jul 201911:40 amRNSAnnual Report and Annual General Meeting Notice
23rd Jul 20193:06 pmRNSDirector/PDMR Shareholding and Total Voting Rights
18th Jul 20197:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
9th Jul 20197:00 amRNSFinal Results, Dividend and Notice of AGM
5th Jun 20197:00 amRNSStrengthening of debt advisory team
4th Apr 20197:00 amRNSTrading Update
7th Mar 20194:19 pmRNSDirector/PDMR Shareholding and Total Voting Rights
11th Feb 20197:00 amRNSLapse of Options
25th Jan 20197:00 amRNSDirector resignation
24th Jan 20197:00 amRNSDeclaration of Interim Dividend
15th Jan 20194:20 pmRNSCancellation of share premium account
4th Jan 20197:00 amRNSGrant of Options under 2019 SAYE Scheme
3rd Jan 20197:00 amRNSResults for the six months ended 31st October 2018
5th Dec 20187:00 amRNSfinnCap Group Plc - Admission to AIM
11th Dec 20132:33 pmRNSResult of EGM
11th Dec 20138:00 amRNSSuspension of listing
11th Dec 20137:30 amRNSSuspension - FRM Credit Alpha Limited
21st Nov 20132:28 pmRNSNet Asset Value(s)
8th Nov 20135:45 pmRNSPublication of Circular
8th Nov 20138:26 amRNSHolding(s) in Company
8th Nov 20138:19 amRNSHolding(s) in Company
5th Nov 20134:18 pmRNSHolding(s) in Company
30th Oct 20132:26 pmRNSNet Asset Value(s)
24th Oct 20133:44 pmRNS7th compulsory partial redemption of shares
21st Oct 201310:13 amRNSNet Asset Value(s)
10th Oct 201310:04 amRNS7th compulsory partial redemption of shares
30th Sep 201310:14 amRNSNet Asset Value(s)
20th Sep 201312:47 pmRNSNet Asset Value(s)
30th Aug 20134:47 pmRNSNet Asset Value(s)
28th Aug 201310:16 amRNSChange in website branding
21st Aug 20133:11 pmRNSNet Asset Value(s)
9th Aug 20135:16 pmRNSNet Asset Value(s)
19th Jul 20131:11 pmRNSNet Asset Value(s)
1st Jul 201310:33 amRNSNet Asset Value(s)
27th Jun 201311:35 amRNSCompany update - Currency Exposure
25th Jun 201311:38 amRNSChange of accounting reference date
21st Jun 201312:26 pmRNSNet Asset Value(s)
17th Jun 20132:54 pmRNSCompany update - Valuation Provision
4th Jun 20139:37 amRNSCompany update - Currency Exposure
31st May 20135:53 pmRNSNet Asset Value(s)
22nd May 20135:34 pmRNSNet Asset Value(s)
26th Apr 20135:31 pmRNSNet Asset Value(s)
22nd Apr 20135:33 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.